Cargando…
The multiple sclerosis rating scale, revised (MSRS-R): Development, refinement, and psychometric validation using an online community
BACKGROUND: In developing the PatientsLikeMe online platform for patients with Multiple Sclerosis (MS), we required a patient-reported assessment of functional status that was easy to complete and identified disability in domains other than walking. Existing measures of functional status were inadeq...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502161/ https://www.ncbi.nlm.nih.gov/pubmed/22709981 http://dx.doi.org/10.1186/1477-7525-10-70 |
_version_ | 1782250279481114624 |
---|---|
author | Wicks, Paul Vaughan, Timothy E Massagli, Michael P |
author_facet | Wicks, Paul Vaughan, Timothy E Massagli, Michael P |
author_sort | Wicks, Paul |
collection | PubMed |
description | BACKGROUND: In developing the PatientsLikeMe online platform for patients with Multiple Sclerosis (MS), we required a patient-reported assessment of functional status that was easy to complete and identified disability in domains other than walking. Existing measures of functional status were inadequate, clinician-reported, focused on walking, and burdensome to complete. In response, we developed the Multiple Sclerosis Rating Scale (MSRS). METHODS: We adapted a clinician-rated measure, the Guy’s Neurological Disability Scale, to a self-report scale and deployed it to an online community. As part of our validation process we reviewed discussions between patients, conducted patient cognitive debriefing, and made minor improvements to form a revised scale (MSRS-R) before deploying a cross-sectional survey to patients with relapsing-remitting MS (RRMS) on the PatientsLikeMe platform. The survey included MSRS-R and comparator measures: MSIS-29, PDDS, NARCOMS Performance Scales, PRIMUS, and MSWS-12. RESULTS: In total, 816 RRMS patients responded (19% response rate). The MSRS-R exhibited high internal consistency (Cronbach’s alpha = .86). The MSRS-R walking item was highly correlated with alternative walking measures (PDDS, ρ = .84; MSWS-12, ρ = .83; NARCOMS mobility question, ρ = .86). MSRS-R correlated well with comparison instruments and differentiated between known groups by PDDS disease stage and relapse burden in the past two years. Factor analysis suggested a single factor accounting for 51.5% of variance. CONCLUSIONS: The MSRS-R is a concise measure of MS-related functional disability, and may have advantages for disease measurement over longer and more burdensome instruments that are restricted to a smaller number of domains or measure quality of life. Studies are underway describing the use of the instrument in contexts outside our online platform such as clinical practice or trials. The MSRS-R is released for use under creative commons license. |
format | Online Article Text |
id | pubmed-3502161 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35021612012-11-21 The multiple sclerosis rating scale, revised (MSRS-R): Development, refinement, and psychometric validation using an online community Wicks, Paul Vaughan, Timothy E Massagli, Michael P Health Qual Life Outcomes Research BACKGROUND: In developing the PatientsLikeMe online platform for patients with Multiple Sclerosis (MS), we required a patient-reported assessment of functional status that was easy to complete and identified disability in domains other than walking. Existing measures of functional status were inadequate, clinician-reported, focused on walking, and burdensome to complete. In response, we developed the Multiple Sclerosis Rating Scale (MSRS). METHODS: We adapted a clinician-rated measure, the Guy’s Neurological Disability Scale, to a self-report scale and deployed it to an online community. As part of our validation process we reviewed discussions between patients, conducted patient cognitive debriefing, and made minor improvements to form a revised scale (MSRS-R) before deploying a cross-sectional survey to patients with relapsing-remitting MS (RRMS) on the PatientsLikeMe platform. The survey included MSRS-R and comparator measures: MSIS-29, PDDS, NARCOMS Performance Scales, PRIMUS, and MSWS-12. RESULTS: In total, 816 RRMS patients responded (19% response rate). The MSRS-R exhibited high internal consistency (Cronbach’s alpha = .86). The MSRS-R walking item was highly correlated with alternative walking measures (PDDS, ρ = .84; MSWS-12, ρ = .83; NARCOMS mobility question, ρ = .86). MSRS-R correlated well with comparison instruments and differentiated between known groups by PDDS disease stage and relapse burden in the past two years. Factor analysis suggested a single factor accounting for 51.5% of variance. CONCLUSIONS: The MSRS-R is a concise measure of MS-related functional disability, and may have advantages for disease measurement over longer and more burdensome instruments that are restricted to a smaller number of domains or measure quality of life. Studies are underway describing the use of the instrument in contexts outside our online platform such as clinical practice or trials. The MSRS-R is released for use under creative commons license. BioMed Central 2012-06-18 /pmc/articles/PMC3502161/ /pubmed/22709981 http://dx.doi.org/10.1186/1477-7525-10-70 Text en Copyright ©2012 Wicks et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Wicks, Paul Vaughan, Timothy E Massagli, Michael P The multiple sclerosis rating scale, revised (MSRS-R): Development, refinement, and psychometric validation using an online community |
title | The multiple sclerosis rating scale, revised (MSRS-R): Development, refinement, and psychometric validation using an online community |
title_full | The multiple sclerosis rating scale, revised (MSRS-R): Development, refinement, and psychometric validation using an online community |
title_fullStr | The multiple sclerosis rating scale, revised (MSRS-R): Development, refinement, and psychometric validation using an online community |
title_full_unstemmed | The multiple sclerosis rating scale, revised (MSRS-R): Development, refinement, and psychometric validation using an online community |
title_short | The multiple sclerosis rating scale, revised (MSRS-R): Development, refinement, and psychometric validation using an online community |
title_sort | multiple sclerosis rating scale, revised (msrs-r): development, refinement, and psychometric validation using an online community |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502161/ https://www.ncbi.nlm.nih.gov/pubmed/22709981 http://dx.doi.org/10.1186/1477-7525-10-70 |
work_keys_str_mv | AT wickspaul themultiplesclerosisratingscalerevisedmsrsrdevelopmentrefinementandpsychometricvalidationusinganonlinecommunity AT vaughantimothye themultiplesclerosisratingscalerevisedmsrsrdevelopmentrefinementandpsychometricvalidationusinganonlinecommunity AT massaglimichaelp themultiplesclerosisratingscalerevisedmsrsrdevelopmentrefinementandpsychometricvalidationusinganonlinecommunity AT wickspaul multiplesclerosisratingscalerevisedmsrsrdevelopmentrefinementandpsychometricvalidationusinganonlinecommunity AT vaughantimothye multiplesclerosisratingscalerevisedmsrsrdevelopmentrefinementandpsychometricvalidationusinganonlinecommunity AT massaglimichaelp multiplesclerosisratingscalerevisedmsrsrdevelopmentrefinementandpsychometricvalidationusinganonlinecommunity |